The combination of vitamin D with sulforaphane at human plasma concentrations is a potential alternative approach to the therapy of advanced prostate cancer because it promotes cytotoxicity, induces reactive species production, autophagy, and DNA damage, and modulates the JNK/MAPK pathway. The gene discussed is MAPK8; the disease is prostate cancer.